However, Sasako et al. showed that interfering with the insulin/IGF-1 signaling pathway by suppressing Akt activity in mouse skeletal muscle can accelerate sarcopenia and reduce lifespan, a phenomenon reversed by deactivating FoxOs rather than activating mTOR (59). The gene discussed is INS; the disease is sarcopenia.